Back to top

A qualitative study that took place in Malawi, Uganda, South Africa and Zimbabwe to understand community belief systems and attitudes that may affect women’s perceptions about and potential interest in using the monthly dapivirine vaginal ring or daily PrEP during pregnancy and breastfeeding. The study involved group discussions with women, male partners and mothers and mothers-in-law of pregnant and breastfeeding women and interviews with community leaders, healthcare providers, midwives and traditional birth attendants, among others. The results, expected in late 2019, will help inform implementation of both the MTN-042 study in pregnant women, and the MTN-043 study, which will enroll women who are breastfeeding and their babies.


The DELIVER and B-PROTECTED Studies: Preventing HIV in Pregnant and Breastfeeding Women

Spotlight on MTN-041 

See Also

MTN-041 Protocol


MTN-041 Study Page